Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis
Ross A. Soo, Zhaojin Chen, Rebecca Teng, et al.
Oncotarget (2018) Vol. 9, Iss. 37, pp. 24801-24820
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
Tobias Bald, Matthew F. Krummel, Mark J. Smyth, et al.
Nature Immunology (2020) Vol. 21, Iss. 8, pp. 835-847
Open Access | Times Cited: 365
Natural killer cell homing and trafficking in tissues and tumors: from biology to application
Guanghe Ran, Yu qing Lin, Lei Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 140
Natural killer cell engagers in cancer immunotherapy: Next generation of immuno‐oncology treatments
Olivier Demaria, Laurent Gauthier, Guilhaume Debroas, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 8, pp. 1934-1942
Closed Access | Times Cited: 115
Therapeutic targeting of regulatory T cells in cancer
Feng Shan, Ashwin Somasundaram, Tullia C. Bruno, et al.
Trends in cancer (2022) Vol. 8, Iss. 11, pp. 944-961
Open Access | Times Cited: 107
CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis
Fangxuan Li, Yao Sun, Jinchao Huang, et al.
Cancer Medicine (2019) Vol. 8, Iss. 17, pp. 7330-7344
Open Access | Times Cited: 113
Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer
Kazue Yoneda, Taiji Kuwata, Masatoshi Kanayama, et al.
British Journal of Cancer (2019) Vol. 121, Iss. 6, pp. 490-496
Open Access | Times Cited: 104
Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategies
Robert J. Walsh, Ross A. Soo
Therapeutic Advances in Medical Oncology (2020) Vol. 12
Open Access | Times Cited: 69
Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond
Eunju Shin, Seong Ho Bak, Tae‐Ho Park, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28
Natural killer cells and type 1 innate lymphoid cells in cancer
Noëlla Lopes, Éric Vivier, Émilie Narni-Mancinelli
Seminars in Immunology (2023) Vol. 66, pp. 101709-101709
Open Access | Times Cited: 24
Spatial immunophenotyping of the tumour microenvironment in non–small cell lung cancer
Max Backman, Carina Strell, Amanda Lindberg, et al.
European Journal of Cancer (2023) Vol. 185, pp. 40-52
Open Access | Times Cited: 23
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
Kabsoo Shin, Joori Kim, Se Jun Park, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 22
NK Cells in the Human Lungs
B. Hervier, Jules Russick, Isabelle Cremer, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 66
Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution
Dávid Dóra, Christopher J. Rivard, Hui Yu, et al.
Molecular Oncology (2020) Vol. 14, Iss. 9, pp. 1947-1965
Open Access | Times Cited: 60
Making cold malignant pleural effusions hot: driving novel immunotherapies
Pranav Murthy, Chigozirim N. Ekeke, Kira L. Russell, et al.
OncoImmunology (2019) Vol. 8, Iss. 4, pp. e1554969-e1554969
Open Access | Times Cited: 58
Peripheral natural killer cells and myeloid-derived suppressor cells correlate with anti-PD-1 responses in non-small cell lung cancer
Je-In Youn, Su-Myeong Park, Seyeon Park, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 52
The Natural Killer–Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy
Erin E Peterson, Kevin C. Barry
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 52
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites
Jordan W. Conway, Robert V. Rawson, Serigne Lo, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 9, pp. e004884-e004884
Open Access | Times Cited: 34
Prognostic significance of tumor infiltrating lymphocytes on first-line pembrolizumab efficacy in advanced non-small cell lung cancer
Kyoichi Kaira, Ou Yamaguchi, Tomonori Kawasaki, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Targeting tumor-infiltrating CCR8+ regulatory T cells induces antitumor immunity through functional restoration of CD4+ Tconvs and CD8+ T cells in colorectal cancer
Qian Chen, Meiying Shen, Min Yan, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Tumor infiltrating T cells influence prognosis in stage I–III non-small cell lung cancer
Arik Bernard Schulze, Georg Evers, Dennis Görlich, et al.
Journal of Thoracic Disease (2020) Vol. 12, Iss. 5, pp. 1824-1842
Open Access | Times Cited: 47
NOX2-Derived Reactive Oxygen Species in Cancer
Hanna Grauers Wiktorin, Ebru Aydin, Kristoffer Hellstrand, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-15
Open Access | Times Cited: 43
A tri-specific killer engager against mesothelin targets NK cells towards lung cancer
Philippa R Kennedy, Daniel A. Vallera, Brianna Ettestad, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Prognostic value of immune cells in the tumor microenvironment of early-stage lung cancer: a meta-analysis
Stephanie Tuminello, Rajwanth Veluswamy, Wil Lieberman‐Cribbin, et al.
Oncotarget (2019) Vol. 10, Iss. 67, pp. 7142-7155
Open Access | Times Cited: 41
Association of tumour and stroma PD-1, PD-L1, CD3, CD4 and CD8 expression with DCB and OS to nivolumab treatment in NSCLC patients pre-treated with chemotherapy
Anna-Larissa N. Niemeijer, S Sahba, Egbert F. Smit, et al.
British Journal of Cancer (2020) Vol. 123, Iss. 3, pp. 392-402
Open Access | Times Cited: 37
PD-L1 as a prognostic biomarker in surgically resectable non- small cell lung cancer: a meta-analysis
Stephanie Tuminello, Daniel Sikavi, Rajwanth Veluswamy, et al.
Translational Lung Cancer Research (2020) Vol. 9, Iss. 4, pp. 1343-1360
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top